Influenza-specific bone marrow plasma cells – responsible for maintaining the level of protective antibodies following a flu shot – are short-lived, and decline to their pre-vaccination levels within a year, researchers report.
Source: Flu vaccine induces short-lived bone marrow plasma cells, limiting vaccination longevity